BeStock  
Stocks › Biotechnology › INCY

Incyte INCY

US equityMarket cap rank #824BiotechnologyCAR-T Therapy
$114.63 −$1.25 (-1.07%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $114.63 0.00%
Open$116.85
Prev close$115.87
Day range$114.28 – $117.51
Volume1.54M
Market cap$23.36B
P/E (TTM)58.5
Dividend yield–

Earnings

Average move on report day±4.5%last 16 reports
Closed higher7 of 1644% of the time
Best reaction+12.0%
Worst reaction-8.2%

Stock move on the day after each report

+2.6%2023/Q4-1.0%2024/Q1-1.2%2024/Q2+12.0%2024/Q3-7.9%2024/Q4+1.5%2025/Q1+10.3%2025/Q2-1.5%2025/Q3-8.2%2025/Q4+2.1%2026/Q1+9.3%2026/Q2-0.1%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q329 Oct 2026Pre Market±7.8%-0.06%Within range
2026/Q228 Jul 2026Pre Market±7.1%+9.30%Bigger than priced
2026/Q128 Apr 2026Pre Market±6.3%+2.12%Within range
2025/Q410 Feb 2026Pre Market±5.6%-8.24%Bigger than priced
2025/Q328 Oct 2025Pre Market±11.0%-1.54%Within range
2025/Q229 Jul 2025Pre Market±6.4%+10.28%Bigger than priced
2025/Q129 Apr 2025Pre Market±8.7%+1.53%Within range
2024/Q410 Feb 2025Pre Market±11.5%-7.86%Within range
2024/Q329 Oct 2024Pre Market±7.5%+12.04%Bigger than priced
2024/Q230 Jul 2024Pre Market±8.2%-1.17%Within range
2024/Q130 Apr 2024Pre Market±8.5%-0.97%Within range
2023/Q413 Feb 2024Pre Market±11.4%+2.59%Within range
2023/Q331 Oct 2023Pre Market±6.8%+3.39%Within range
2023/Q21 Aug 2023Pre Market±7.1%-0.05%Within range
2023/Q12 May 2023Pre Market±6.2%-7.14%Bigger than priced
2022/Q47 Feb 2023Pre Market±5.8%-4.03%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q3, ended Sep 2026

Revenue$1.56B+14.0% YoY
Operating profit-$707.45M-264.0% YoY
Net profit-$784.80M-285.0% YoY
Diluted EPS-$3.86-282.9% YoY
Free cash flow-$690.95M-233.0% YoY
Operating cash flow-$675.32M

Revenue, last 8 quarters

$1.2BDec '24$1.1BMar '25$1.2BJun '25$1.4BSep '25$1.5BDec '25$1.3BMar '26$1.7BJun '26$1.6BSep '26

Net profit, last 8 quarters

$201.2MDec '24$158.2MMar '25$405.0MJun '25$424.2MSep '25$299.3MDec '25$303.3MMar '26$585.6MJun '26$-784.8MSep '26

Profitability & balance sheet

Gross margin92.7%
Operating margin11.7%
Net margin6.7%
Return on equity7.8%
Return on assets5.9%
Return on invested capital6.2%
Current ratio3.84
Liabilities / assets22.6%
Cash & investments$3.85B
Total debt$27.63M
Net cash (debt)$3.83B
Free cash flow / sales11.3%

Discussion

No comments yet — be the first to weigh in on INCY.

Sign in to join the discussion.

Scroll to Top